Sandostatin Injection, Solution
Product Images NDC 0078-0182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sandostatin (NDC 0078-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Octreotide Acetate Amino Acid Sequence (Sandostatin 02)
The text appears to be a molecular formula. Specifically, it is the formula for a peptide molecule made up of the amino acid sequence: H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol. It also includes a side chain notation (*CH;COOH) that may indicate a modification or functionalization of the peptide molecule.*
Principal Display Panelpackage Label – 50 Mcg/mlrx Only Ndc 0078 0180 01sandostatin Injection Octreotide Acetate50 Mcg/ml (0.05 mg/ml) (Sandostatin 03)
Principal Display Panelpackage Label – 100 Mcg/mlrx Only Ndc 0078 0181 01sandostatin Injectionoctreotide Acetate100 Mcg/ml (0.1 mg/ml) (Sandostatin 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.